Φορτώνει......
Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
Biotherapeutics are a rapidly growing portion of the total pharmaceutical market accounting for almost one-half of recent new drug approvals. A major portion of these approvals each year are monoclonal antibodies (mAbs). During development, non-clinical pharmacology and toxicology testing of mAbs di...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Mol Sci |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6274697/ https://ncbi.nlm.nih.gov/pubmed/30469350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113685 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|